The Antibody Society has partnered with numerous conference organizers, including KNect365, Cambridge Healthtech Institute, Hanson Wade and Terrapinn, to ensure our members receive substantial discounts on meeting registration fees. As a courtesy, we also list meetings held by non-profit organizations, such as Gordon Research Conferences and KeyStone Symposia.
Bispecific Antibody Congress
August 20-23, 2018, Washington DC
Join over 150 international participant at the Bispecific Antibody Pipeline Congress being held August 20-23 in the Washington, DC area. This 3-day event will unite all the key opinion leaders including regulators, clinicians, and industry experts to deepen our understanding of bispecific therapeutics and exchange innovative ideas to foster meaningful research collaborations. View the speaker lineup & program agenda online.
Society members save 20% on the registration fee!
Immuno-Oncology Summit
August 27-31, 2018, Boston, MA
Over the past 6 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research. The comprehensive 5-day, 12-track program covers immunomodulatory antibody engineering and emerging immuno-oncology targets, combination immunotherapy, preclinical and translational IO, predictive biomarkers and companion diagnostics, adoptive T cell therapy, oncolytic viruses and personalized cancer vaccines. Now in its 6th year, the IO Summit consistently delivers a cutting-edge agenda, 600+ senior delegates, and a sold-out exhibit hall. Please join us in Boston for comprehensive scientific coverage and unparalleled networking opportunities at CHI’s Immuno-Oncology Summit 2018! Learn more here.
Society members save 20% on the registration fee!
9th Annual World Bispecific Summit: Pioneering Novel Bispecific Applications Into The Clinic
September 18-20, 2018, Boston, MA
As the only event to focus exclusively on bispecifics, the World Bispecific Summit 2018 will offer a greater breadth and depth of technical content than any other conference.
This content will arm you with the insights required to tackle the most challenging developmental hurdles encountered when working with these therapeutics, as well as shining a light on novel applications of bispecifics.
Join your peers to discuss strategies to select and validate synergistic targets, understand the true potential of novel formats, streamline CMC and developability processes and maximize clinical performance. Leave the World Bispecific Summit with clear insights that will dramatically improve the success of your bispecific development.
See the complete agenda and speaker line-up here
Society members save 20% on the registration fee! Contact us at membership@antibodysociety.org for the code.
European Antibody Congress
October 29-31, 2018, Basel
In the 13 years since its inauguration, countless breakthroughs, advancements and achievements have been showcased for the first time at the European Antibody Congress, and born out of collaborations and partnerships that were catalyzed by, or initiated at, the European Antibody Congress. The 2018 Congress will include more streams, with a focus on protein engineering, antibody R&D, CMC and developability and bioprocessing. Brand new topics include AI for antibody discovery, co-formulation of biologics, safety and toxicity, and orally bioavailable biologics.
As part of the Festival of Biologics, the European Antibody Congress is co-located with World Biosimilar Congress, World Immunotherapy Congress, HPAPI World Congress and Clinical Trials Europe. Attendees will have access to plenty of content across the 3 days and more networking opportunities than ever before with over 800+ leading industry professionals.
For more information and to register click here.
Society members save 15% on the registration fees for any/all of these co-located Congresses! Contact us at membership@antibodysociety.org for the codes.
World Biosimilar Congress
October 29-31, 2018, Basel
After several approvals in the US, the biosimilar industry is now finally ready to fulfil its promise and become a multi-billion-dollar business providing real benefits to healthcare. On the back of these approvals it is becoming a far more crowded and competitive landscape, but getting a biosimilar to patients still presents a number of challenges that the World Biosimilar Congress will address. Across the two days, industry and thought-leading speakers from across the globe will come together to network and discuss the key issues on biosimilar drug development, commercialization, market access and healthcare uptake.
For more information and to register click here.
Society members save 15% on the co-located European Antibody Congress, World Biosimilar Congress, World Immunotherapy Congress, HPAPI World Congress and Clinical Trials Europe! Contact us at membership@antibodysociety.org for the codes.
World Immunotherapy Congress
October 29-31, 2018, Basel
The World Immunotherapy Congress will bring together the full community and provide a single meeting point for the whole value chain. It is where science meets business to make immunotherapy the cornerstone of the fight against cancer. The third instalment of the World Immunotherapy Congress includes more content, allowing participants to delve deeper into the case studies, clinical trials and immunotherapy discovery than ever before. With two full tracks of content over the three days, covering oncology, non-oncology (e.g., infectious disease, inflammation, autoimmune disorders, organ transplant, neurological disease), oncolytics, cancer vaccines, safety, and efficacy, all bases will be covered.
For more information and to register click here.
Society members save 15% on the co-located European Antibody Congress, World Biosimilar Congress, World Immunotherapy Congress, HPAPI World Congress and Clinical Trials Europe! Contact us at membership@antibodysociety.org for the codes.
World HPAPI Congress
October 29-31, 2018, Basel
The HPAPI World Congress has been developed over 4 years as the only two-tracked Congress focused on high potency API. The event has a strong focus on the management of HPAPI, Design of Facilities, Innovation of New HPAPIs, SHE, Working with CMOs and case studies. The Congress includes a diverse group of companies and consultants along with a mix of different formats to provide the best possible learning experience for participants. Many first releases will be presented, including understanding a new class of ADC linker and discussing new factories in development. A range of new questions about the management of HPAPIs including the banding of agents will be discussed.
For more information and to register click here.
Society members save 15% on the co-located European Antibody Congress, World Biosimilar Congress, World Immunotherapy Congress, HPAPI World Congress and Clinical Trials Europe! Contact us at membership@antibodysociety.org for the codes.
Clinical Trials Europe
October 29-31, 2018, Basel
Over recent years, there has been increased discussion about the challenges facing pharma and biotech clinical trials. With only 32% of drugs making it through to Phase III trials, and 10% making it to market, it is vital that the industry focuses on new ways to increase this success rate. This event breaks down the silos of clinical trial development, bringing together 30+ speakers from pharma, biotech, CROs and technology innovators, and will help tackle the challenges around clinical trials, such as: Data and Analytics, Patient Recruitment, Planning and Trial Design, Site Selection and Management and much more.
For more information and to register click here.
Society members save 15% on the co-located European Antibody Congress, World Biosimilar Congress, World Immunotherapy Congress, HPAPI World Congress and Clinical Trials Europe! Contact us at membership@antibodysociety.org for the codes.
BTW, The Antibody Society suggests that companies should consider developing antibody therapeutics if they want to increase their success rates. While the Phase 1 to marketing approval success rate may be 10% for small molecule drugs, it is 20-24% for antibody therapeutics. Contact us for more information on this topic.
PEGS Europe
Protein & Antibody Engineering Summit
November 12- 16, 2018 | Lisbon, Portugal
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2017, for the sixth year in a row, a record number of delegates participated in PEGS Europe, as more than 900 attendees from 35 countries convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering.
View the speaker lineup & program agenda online.
Society members save 20% on the registration fee!
Immunotherapy for Infectious Diseases Conference
November 12-14, 2018, Galveston, TX, USA
Immunotherapy represents a promising approach to treating life-threatening infections especially at the time of global antimicrobial resistance, emerging and re-emerging infectious diseases and few antibiotics in the development. The Immunotherapy for Infectious Diseases conference is organized at the interface between academia and industry and will showcase recent progress, and serve as a forum for the exchange of ideas and cross-disciplinary collaborations.
The conference will feature sessions on :
– Antibody based drug development
– Immunotherapy against viral infections
– Immunotherapy against bacterial infections
– Immunotherapy against emerging infections
– Emerging novel therapeutics showcase
– Challenges of immunotherapy against infectious diseases
World ADC
November 12-15, 2018, San Diego, CA
World ADC San Diego is the industry’s longest standing and most comprehensive antibody-drug conjugate conference. Across multiple-streams of learning, World ADC will cover every element of ADC drug development from construct design to improving preclinical predictability and product manufacturability. This leading antibody-drug conjugate event will provide you with an unparalleled breadth and depth of content.
Don’t miss this opportunity to join your fellow scientists at the heart of the ADC community. Join 650+ of your peers, from 220 organizations for your most valuable ADC learning and networking opportunity of 2018.
Find out more.
Early-bird discount deadlines occur on Sep 7, Oct 5. Society members can receive a 10% discount on the current registration fee after Sep 7, and a 15% discount after Oct 5. Contact us at membership@antibodysociety.org for the code.
Computational Drug Development for Biologics
November 13-15, 2018, Woburn, MA
Computational Drug Development (CDD) for Biologics is dedicated to harnessing the power of in silico tools to de-risk biotherapeutic development from early discovery through to late preclinical development. Returning 13-15 November, the 3rd Annual meeting remains the only industry-centric meeting solely dedicated to exploring the in silico prediction, design, and modelling of biotherapeutics. Across 3 days of intensive presentations, discussion and debate, the event will again unite computational leaders from pioneering pharmaceutical organizations, academic and software development labs.
This year, topics will span the in silico prediction, design, and modelling of biologics. With a greater focus beyond applications for mAbs, the agenda will showcase advances with computational tools for vaccine, enzyme, multi-specific and linker-based biologics and highlight the iterative experimental processes.
Register now to can save up to $700! Visit http://cdd-biologics.com/ or email info@hansonwade.com to find out more.
Antibody Engineering & Therapeutics
December 9-13, 2018, San Diego, CA USA
Antibody Engineering & Therapeutics taking place December 9-13, 2018 in San Diego, CA is the largest meeting bringing you the latest antibody science, technologies and partners needed to accelerate next generation antibodies towards commercial success. It is the annual meeting of The Antibody Society, whose members are responsible for designing the scientific program and act as the session Chairs. We invite you to network with your fellow Society members at Antibody Engineering & Therapeutics!
For over 25 years, renowned academic and industry scientists from around the world have convened to share best practices and scientific results to accelerate antibody research, discovery efforts and clinical programs. With 900+ attendees, 135+ speaker presentations and 75+ exhibitors and 135+ scientific posters focused on antibody science and technology, Antibody Engineering & Therapeutics is the global meeting place for antibody science, technology and networking.
New for 2018!
· New Workshop on “Immuno-Engineering 101: An Introduction to the Immune Systems”
· New Session Focusing on the “Microbiome”
· New Session on “Novel Methods to Interrogate Receptors as Targets”
· New Session on “Immunogenicity”
Click here for more information and to register for Antibody Engineering & Therapeutics.
The Antibody Society members receive a 15% discount on the registration fee. Contact us at membership@antibodysociety.org for the code.
Phar-East
March 19-20, 2019, Singapore
Returning in 2019 after a successful 2018 debut, Phar-East will once again bring together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and more to share their expertise and chart Asia’s path forward.
On 19 – 20 March, the 2-day conference will be exploring 6 of the most exciting areas of Asian pharma:
Immunotherapy
Market access
Regulatory affairs
Pharma 4.0
Clinical Trials
Biotech Investment
Pre-conference workshops are available on 18 March.
Join over 800 industry leaders now by registering here.
Society members save 15% on the registration fee! Contact us at membership@antibodysociety.org for the code.
